Table 5 Logistic regression of signing advance directives among cancer patients

Age

1.00 (0.99, 1.01)

0.466

1.01 (0.99, 1.03)

0.242

 Male (vs female)

0.73 (0.53, 1.00)

0.05*

0.73 (0.43, 1.26)

0.257

 Married (vs not married)

1.44 (0.93, 2.24)

0.102

1.36 (0.67, 2.75)

0.390

  ≥ 7 (vs 0–6)

1.42 (1.02, 1.98)

0.039*

1.62 (1.00, 2.61)

0.051

 Yes (vs no)

1.13 (0.79, 1.61)

0.522

1.36 (0.83, 2.23)

0.221

 Family members (vs self)

2.99 (1.41, 6.33)

0.004*

3.48 (1.30, 9.33)

0.013*

 Care homes (vs self)

1.73 (0.55, 5.48)

0.349

1.29 (0.32, 5.15)

0.721

 Friends/maid (vs self)

8.08 (2.54, 25.76)

< 0.001*

9.21 (1.69, 50.09)

0.010*

 Yes (vs no)

10.90 (3.99, 29.76)

< 0.001*

11.85 (4.27, 32.89)

< 0.001*

 Brain/CNS Lymphoma

0.55 (0.20, 1.55)

0.260

0.81 (0.16, 4.11)

0.801

 Breast cancer

1.26 (0.50, 3.12)

0.626

0.79 (0.20, 3.17)

0.740

 Cervical cancer

0.95 (0.35, 2.59)

0.926

0.31 (0.09, 1.11)

0.071

 Cholangiocarcinoma

1.69 (0.39, 7.44)

0.485

1.44 (0.18, 11.74)

0.736

 Colorectal cancer

1.19 (0.64, 2.23)

0.583

1.02 (0.39, 2.66)

0.966

 Esophageal cancer

0.55 (0.28, 1.07)

0.080

0.66 (0.23, 1.87)

0.430

 Head and neck cancer

0.81 (0.45, 1.44)

0.469

0.54 (0.22, 1.30)

0.168

 Hematological malignancies

0.69 (0.36, 1.31)

0.257

0.58 (0.23, 1.48)

0.256

 Liver cancer

1.11 (0.67, 1.83)

0.688

0.98 (0.46, 2.06)

0.951

 Ovarian cancer

3.39 (0.45, 25.73)

0.238

0.73 (0.09, 6.27)

0.776

 Pancreatic cancer

0.75 (0.34, 1.66)

0.481

0.79 (0.21, 2.99)

0.733

 Prostate cancer

1.13 (0.38, 3.37)

0.828

1.23 (0.15, 10.09)

0.848

 Stomach cancer

1.03 (0.51, 2.06)

0.946

1.05 (0.36, 3.08)

0.924

 Urological cancer

1.17 (0.47, 2.92)

0.735

0.62 (0.19, 2.02)

0.427

 Other cancer (vs lung cancer)

0.65 (0.34, 1.26)

0.203

0.77 (0.26, 2.29)

0.639